This was a descriptive, correlational study whose
target population included a convenience sample of
patients with primary breast cancer, aged 18 years and
older, literate in Hebrew, with no comorbidities that
could affect their QOL according to their individual
perception, and who came for follow-up at the oncology
clinic of the tertiary medical center where the study
was conducted. All participants had been prescribed
adjuvant hormonal treatment for at least three months.
The study was approved by the institutional ethics
committee.